diseaseId	diseaseName	drugId	drugName	type	mechanismOfAction	actionType	symbol	name	phase	status	source
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB4	NADH:ubiquinone oxidoreductase subunit B4	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4A	phosphodiesterase 4A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE8A	phosphodiesterase 8A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE9A	phosphodiesterase 9A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE7B	phosphodiesterase 7B	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA6	NADH:ubiquinone oxidoreductase subunit A6	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC1	NADH:ubiquinone oxidoreductase subunit C1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL121	ROSIGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	4	Terminated	https://clinicaltrials.gov/ct2/show/NCT01406704
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4L2	NDUFA4 mitochondrial complex associated like 2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS4	NADH:ubiquinone oxidoreductase subunit S4	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6A	phosphodiesterase 6A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS8	NADH:ubiquinone oxidoreductase core subunit S8	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF2	NADH:ubiquinone oxidoreductase complex assembly factor 2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC2	NADH:ubiquinone oxidoreductase subunit C2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1B	phosphodiesterase 1B	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF3	NADH:ubiquinone oxidoreductase complex assembly factor 3	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL414357	EXENATIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	4	Completed	https://clinicaltrials.gov/ct2/show/NCT01208649
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2105711	TOFOGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02649465
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA2	NADH:ubiquinone oxidoreductase subunit A2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1201497	INSULIN GLARGINE	Protein	Insulin receptor agonist		INSR	insulin receptor	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6D	phosphodiesterase 6D	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6H	phosphodiesterase 6H	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	Adenosine A2 receptor antagonist		ADORA2B	adenosine A2b receptor	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4084119	LIRAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE10A	phosphodiesterase 10A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1491	AMLODIPINE	Small molecule	Voltage-gated L-type calcium channel blocker		CACNA1F	calcium voltage-gated channel subunit alpha1 F	4	Unknown status	https://clinicaltrials.gov/ct2/show/NCT02213224
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL429910	DAPAGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	4	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05254626
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE5A	phosphodiesterase 5A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE3B	phosphodiesterase 3B	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	4	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05813249
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB10	NADH:ubiquinone oxidoreductase subunit B10	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE2A	phosphodiesterase 2A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA5	NADH:ubiquinone oxidoreductase subunit A5	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV1	NADH:ubiquinone oxidoreductase core subunit V1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1481	GLIMEPIRIDE	Small molecule	Sulfonylurea receptor 1, Kir6.2 blocker		KCNJ11	potassium inwardly rectifying channel subfamily J member 11	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02649465
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND2	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6B	phosphodiesterase 6B	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1491	AMLODIPINE	Small molecule	Voltage-gated L-type calcium channel blocker		CACNA1D	calcium voltage-gated channel subunit alpha1 D	4	Unknown status	https://clinicaltrials.gov/ct2/show/NCT02213224
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1491	AMLODIPINE	Small molecule	Voltage-gated L-type calcium channel blocker		CACNA1S	calcium voltage-gated channel subunit alpha1 S	4	Unknown status	https://clinicaltrials.gov/ct2/show/NCT02213224
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA10	NADH:ubiquinone oxidoreductase subunit A10	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL595	PIOGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	4	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05813249,https://clinicaltrials.gov/ct2/show/NCT05254626
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4L	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1422	SITAGLIPTIN	Small molecule	Dipeptidyl peptidase IV inhibitor		DPP4	dipeptidyl peptidase 4	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF4	NADH:ubiquinone oxidoreductase complex assembly factor 4	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB8	NADH:ubiquinone oxidoreductase subunit B8	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA1	NADH:ubiquinone oxidoreductase subunit A1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS3	NADH:ubiquinone oxidoreductase core subunit S3	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS7	NADH:ubiquinone oxidoreductase core subunit S7	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2110731	TOFOGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02649465
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA12	NADH:ubiquinone oxidoreductase subunit A12	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS5	NADH:ubiquinone oxidoreductase subunit S5	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND1	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1017	TELMISARTAN	Small molecule	Type-1 angiotensin II receptor antagonist		AGTR1	angiotensin II receptor type 1	4	Unknown status	https://clinicaltrials.gov/ct2/show/NCT02213224
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB1	NADH:ubiquinone oxidoreductase subunit B1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4D	phosphodiesterase 4D	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA11	NADH:ubiquinone oxidoreductase subunit A11	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1491	AMLODIPINE	Small molecule	Voltage-gated L-type calcium channel blocker		CACNA1C	calcium voltage-gated channel subunit alpha1 C	4	Unknown status	https://clinicaltrials.gov/ct2/show/NCT02213224
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1138	EZETIMIBE	Small molecule	Niemann-Pick C1-like protein 1 inhibitor		NPC1L1	NPC1 like intracellular cholesterol transporter 1	4	Unknown status	https://clinicaltrials.gov/ct2/show/NCT01950884
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA13	NADH:ubiquinone oxidoreductase subunit A13	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV2	NADH:ubiquinone oxidoreductase core subunit V2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS6	NADH:ubiquinone oxidoreductase subunit S6	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1481	GLIMEPIRIDE	Small molecule	Sulfonylurea receptor 1, Kir6.2 blocker		ABCC8	ATP binding cassette subfamily C member 8	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02649465
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL787	MONTELUKAST	Small molecule	Cysteinyl leukotriene receptor 1 antagonist		CYSLTR1	cysteinyl leukotriene receptor 1	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04537780
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS2	NADH:ubiquinone oxidoreductase core subunit S2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND5	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA3	NADH:ubiquinone oxidoreductase subunit A3	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB6	NADH:ubiquinone oxidoreductase subunit B6	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE3A	phosphodiesterase 3A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6G	phosphodiesterase 6G	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND6	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1C	phosphodiesterase 1C	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	Adenosine A2 receptor antagonist		ADORA2A	adenosine A2a receptor	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4B	phosphodiesterase 4B	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL595	PIOGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	4	Completed	https://clinicaltrials.gov/ct2/show/NCT00227110,https://clinicaltrials.gov/ct2/show/NCT01002547
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB11	NADH:ubiquinone oxidoreductase subunit B11	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV3	NADH:ubiquinone oxidoreductase subunit V3	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	Inhibitor	GPD2	glycerol-3-phosphate dehydrogenase 2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4	NDUFA4 mitochondrial complex associated	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1715	PIOGLITAZONE HYDROCHLORIDE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	4	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05813249
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1A	phosphodiesterase 1A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE8B	phosphodiesterase 8B	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE7A	phosphodiesterase 7A	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB9	NADH:ubiquinone oxidoreductase subunit B9	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6C	phosphodiesterase 6C	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4C	phosphodiesterase 4C	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA9	NADH:ubiquinone oxidoreductase subunit A9	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1551	URSODIOL	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	4	Completed	https://clinicaltrials.gov/ct2/show/NCT04977661
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB7	NADH:ubiquinone oxidoreductase subunit B7	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND3	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB2	NADH:ubiquinone oxidoreductase subunit B2	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2107830	EMPAGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	4	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT04642261
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1581	PERINDOPRIL	Small molecule	Angiotensin-converting enzyme inhibitor		ACE	angiotensin I converting enzyme	4	Unknown status	https://clinicaltrials.gov/ct2/show/NCT02213224
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB3	NADH:ubiquinone oxidoreductase subunit B3	4	Completed	https://clinicaltrials.gov/ct2/show/NCT02147925
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1042	CHOLECALCIFEROL	Small molecule	Vitamin D receptor agonist		VDR	vitamin D receptor	3	Completed	https://clinicaltrials.gov/ct2/show/NCT02098317
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND5	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB8	NADH:ubiquinone oxidoreductase subunit B8	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA5	NADH:ubiquinone oxidoreductase subunit A5	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6A	phosphodiesterase 6A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4	NDUFA4 mitochondrial complex associated	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1536	ERGOCALCIFEROL	Small molecule	Vitamin D receptor agonist		VDR	vitamin D receptor	3	Unknown status	https://clinicaltrials.gov/ct2/show/NCT01623024
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3261331	RESMETIROM	Small molecule	Thyroid hormone receptor beta-1 agonist		THRB	thyroid hormone receptor beta	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT04197479
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE3A	phosphodiesterase 3A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB3	NADH:ubiquinone oxidoreductase subunit B3	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	Inhibitor	GPD2	glycerol-3-phosphate dehydrogenase 2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA1	NADH:ubiquinone oxidoreductase subunit A1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1496	ROSUVASTATIN	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	3	Not yet recruiting	https://clinicaltrials.gov/ct2/show/NCT05731596
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4L	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA2	NADH:ubiquinone oxidoreductase subunit A2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4091374	LANIFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARG	peroxisome proliferator activated receptor gamma	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04849728
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1042	CHOLECALCIFEROL	Small molecule	Vitamin D receptor agonist		VDR	vitamin D receptor	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05613192
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS2	NADH:ubiquinone oxidoreductase core subunit S2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE3B	phosphodiesterase 3B	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA12	NADH:ubiquinone oxidoreductase subunit A12	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4091374	LANIFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARD	peroxisome proliferator activated receptor delta	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04849728
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB1	NADH:ubiquinone oxidoreductase subunit B1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS4	NADH:ubiquinone oxidoreductase subunit S4	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4B	phosphodiesterase 4B	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA13	NADH:ubiquinone oxidoreductase subunit A13	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS8	NADH:ubiquinone oxidoreductase core subunit S8	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS7	NADH:ubiquinone oxidoreductase core subunit S7	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB4	NADH:ubiquinone oxidoreductase subunit B4	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3261331	RESMETIROM	Small molecule	Thyroid hormone receptor beta-1 agonist		THRB	thyroid hormone receptor beta	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT03900429
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1A	phosphodiesterase 1A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC1	NADH:ubiquinone oxidoreductase subunit C1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND2	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE7A	phosphodiesterase 7A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE9A	phosphodiesterase 9A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE2A	phosphodiesterase 2A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4L2	NDUFA4 mitochondrial complex associated like 2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF2	NADH:ubiquinone oxidoreductase complex assembly factor 2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6D	phosphodiesterase 6D	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4091374	LANIFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARA	peroxisome proliferator activated receptor alpha	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04849728
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA6	NADH:ubiquinone oxidoreductase subunit A6	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF4	NADH:ubiquinone oxidoreductase complex assembly factor 4	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4A	phosphodiesterase 4A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA9	NADH:ubiquinone oxidoreductase subunit A9	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF3	NADH:ubiquinone oxidoreductase complex assembly factor 3	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL191	LOSARTAN	Small molecule	Type-1 angiotensin II receptor antagonist		AGTR1	angiotensin II receptor type 1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT01051219
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA11	NADH:ubiquinone oxidoreductase subunit A11	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA10	NADH:ubiquinone oxidoreductase subunit A10	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1C	phosphodiesterase 1C	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB2	NADH:ubiquinone oxidoreductase subunit B2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB6	NADH:ubiquinone oxidoreductase subunit B6	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1B	phosphodiesterase 1B	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA3	NADH:ubiquinone oxidoreductase subunit A3	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4C	phosphodiesterase 4C	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS6	NADH:ubiquinone oxidoreductase subunit S6	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL595	PIOGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	3	Not yet recruiting	https://clinicaltrials.gov/ct2/show/NCT05605158
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE7B	phosphodiesterase 7B	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	Adenosine A2 receptor antagonist		ADORA2B	adenosine A2b receptor	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV3	NADH:ubiquinone oxidoreductase subunit V3	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS5	NADH:ubiquinone oxidoreductase subunit S5	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL595	PIOGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2110727	CENICRIVIROC	Small molecule	C-C chemokine receptor type 5 antagonist		CCR5	C-C motif chemokine receptor 5	3	Terminated	https://clinicaltrials.gov/ct2/show/NCT03028740
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE10A	phosphodiesterase 10A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6G	phosphodiesterase 6G	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB7	NADH:ubiquinone oxidoreductase subunit B7	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND1	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6C	phosphodiesterase 6C	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC2	NADH:ubiquinone oxidoreductase subunit C2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2107830	EMPAGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	3	Not yet recruiting	https://clinicaltrials.gov/ct2/show/NCT05605158
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL135	ESTRADIOL	Small molecule	Estrogen receptor alpha agonist		ESR1	estrogen receptor 1	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04833140
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE8A	phosphodiesterase 8A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4D	phosphodiesterase 4D	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND6	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND3	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04822181
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6B	phosphodiesterase 6B	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV2	NADH:ubiquinone oxidoreductase core subunit V2	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL566315	OBETICHOLIC ACID	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT02548351
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6H	phosphodiesterase 6H	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE5A	phosphodiesterase 5A	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL429910	DAPAGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT03723252
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE8B	phosphodiesterase 8B	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3916717	SELONSERTIB	Small molecule	Mitogen-activated protein kinase kinase kinase 5 inhibitor		MAP3K5	mitogen-activated protein kinase kinase kinase 5	3	Terminated	https://clinicaltrials.gov/ct2/show/NCT03053063,https://clinicaltrials.gov/ct2/show/NCT03053050
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2110727	CENICRIVIROC	Small molecule	C-C chemokine receptor type 2 antagonist		CCR2	C-C motif chemokine receptor 2	3	Terminated	https://clinicaltrials.gov/ct2/show/NCT03028740
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	Adenosine A2 receptor antagonist		ADORA2A	adenosine A2a receptor	3	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05284448
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV1	NADH:ubiquinone oxidoreductase core subunit V1	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB11	NADH:ubiquinone oxidoreductase subunit B11	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1201134	LUBIPROSTONE	Small molecule	Chloride channel protein 2 opener		CLCN2	chloride voltage-gated channel 2	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05768334
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB10	NADH:ubiquinone oxidoreductase subunit B10	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS3	NADH:ubiquinone oxidoreductase core subunit S3	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3261331	RESMETIROM	Small molecule	Thyroid hormone receptor beta-1 agonist		THRB	thyroid hormone receptor beta	3	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04951219
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB9	NADH:ubiquinone oxidoreductase subunit B9	3	Completed	https://clinicaltrials.gov/ct2/show/NCT05521633
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL191	LOSARTAN	Small molecule	Type-1 angiotensin II receptor antagonist		AGTR1	angiotensin II receptor type 1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297576	EFINOPEGDUTIDE	Protein	Glucagon receptor agonist		GCGR	glucagon receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04944992
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS8	NADH:ubiquinone oxidoreductase core subunit S8	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1201608	MUROMONAB-CD3	Antibody	T cell surface glycoprotein CD3 inhibitor		CD3E	CD3 epsilon subunit of T-cell receptor complex	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01205087
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3916717	SELONSERTIB	Small molecule	Mitogen-activated protein kinase kinase kinase 5 inhibitor		MAP3K5	mitogen-activated protein kinase kinase kinase 5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02781584,https://clinicaltrials.gov/ct2/show/NCT03449446
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP8	caspase 8	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV3	NADH:ubiquinone oxidoreductase subunit V3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1751	DIGOXIN	Small molecule	Sodium/potassium-transporting ATPase inhibitor		ATP1A2	ATPase Na+/K+ transporting subunit alpha 2	2	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT04216693
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP12	caspase 12 (gene/pseudogene)	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE8A	phosphodiesterase 8A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00590161,https://clinicaltrials.gov/ct2/show/NCT00267670
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL431733	NAMODENOSON	Small molecule	Adenosine A3 receptor agonist		ADORA3	adenosine A3 receptor	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04697810
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL982	NALMEFENE	Small molecule	Opioid receptors; mu/kappa/delta antagonist		OPRM1	opioid receptor mu 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02442687
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA3	NADH:ubiquinone oxidoreductase subunit A3	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1751	DIGOXIN	Small molecule	Sodium/potassium-transporting ATPase inhibitor		ATP1A1	ATPase Na+/K+ transporting subunit alpha 1	2	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT04216693
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297578	PEGBELFERMIN	Protein	FGF1/KLB agonist		FGF1	fibroblast growth factor 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02413372,https://clinicaltrials.gov/ct2/show/NCT03400163
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4650349	CHIGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARD	peroxisome proliferator activated receptor delta	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05193916
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA11	NADH:ubiquinone oxidoreductase subunit A11	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS5	NADH:ubiquinone oxidoreductase subunit S5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297613	CILOFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03987074,https://clinicaltrials.gov/ct2/show/NCT03449446,https://clinicaltrials.gov/ct2/show/NCT02854605,https://clinicaltrials.gov/ct2/show/NCT02781584
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA13	NADH:ubiquinone oxidoreductase subunit A13	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3407547	FIRSOCOSTAT	Small molecule	Acetyl-CoA carboxylase negative allosteric modulator		ACACB	acetyl-CoA carboxylase beta	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03449446,https://clinicaltrials.gov/ct2/show/NCT03987074,https://clinicaltrials.gov/ct2/show/NCT02781584,https://clinicaltrials.gov/ct2/show/NCT02856555
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND6	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB3	NADH:ubiquinone oxidoreductase subunit B3	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL982	NALMEFENE	Small molecule	Opioid receptors; mu/kappa/delta antagonist		OPRK1	opioid receptor kappa 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02442687
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS7	NADH:ubiquinone oxidoreductase core subunit S7	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP2	caspase 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4298055	ALDAFERMIN	Protein	FGF1/KLB activator		FGF1	fibroblast growth factor 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02443116,https://clinicaltrials.gov/ct2/show/NCT03912532
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297577	BELAPECTIN	Unknown	Galectin-3 inhibitor		LGALS3	galectin 3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02421094
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297530	SAROGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05211284
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND1	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04971785
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB2	NADH:ubiquinone oxidoreductase subunit B2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS2	NADH:ubiquinone oxidoreductase core subunit S2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4298055	ALDAFERMIN	Protein	FGFR4-KLB activator		FGFR4	fibroblast growth factor receptor 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02443116,https://clinicaltrials.gov/ct2/show/NCT03912532
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA2	NADH:ubiquinone oxidoreductase subunit A2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2110727	CENICRIVIROC	Small molecule	C-C chemokine receptor type 5 antagonist		CCR5	C-C motif chemokine receptor 5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03517540
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3545392	MT-3995	Small molecule	Mineralocorticoid receptor antagonist		NR3C2	nuclear receptor subfamily 3 group C member 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02923154
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP14	caspase 14	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF4	NADH:ubiquinone oxidoreductase complex assembly factor 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND2	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1551	URSODIOL	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT02244944
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS5	NADH:ubiquinone oxidoreductase subunit S5	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1566	ACARBOSE	Oligosaccharide	Maltase-glucoamylase inhibitor		MGAM	maltase-glucoamylase	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT00677521
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA1	NADH:ubiquinone oxidoreductase subunit A1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4	NDUFA4 mitochondrial complex associated	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS6	NADH:ubiquinone oxidoreductase subunit S6	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA6	NADH:ubiquinone oxidoreductase subunit A6	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL431733	NAMODENOSON	Small molecule	Adenosine A3 receptor agonist		ADORA3	adenosine A3 receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02927314
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF2	NADH:ubiquinone oxidoreductase complex assembly factor 2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA11	NADH:ubiquinone oxidoreductase subunit A11	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4B	phosphodiesterase 4B	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00590161,https://clinicaltrials.gov/ct2/show/NCT00267670
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4C	phosphodiesterase 4C	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB10	NADH:ubiquinone oxidoreductase subunit B10	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA1	NADH:ubiquinone oxidoreductase subunit A1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1751	DIGOXIN	Small molecule	Sodium/potassium-transporting ATPase inhibitor		ATP1A3	ATPase Na+/K+ transporting subunit alpha 3	2	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT04216693
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Suspended	https://clinicaltrials.gov/ct2/show/NCT05424003
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	Inhibitor	GPD2	glycerol-3-phosphate dehydrogenase 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297625	LICOGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 1 inhibitor		SLC5A1	solute carrier family 5 member 1	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04065841
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV3	NADH:ubiquinone oxidoreductase subunit V3	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS4	NADH:ubiquinone oxidoreductase subunit S4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	Adenosine A2 receptor antagonist		ADORA2B	adenosine A2b receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL193240	ROFLUMILAST	Small molecule	Phosphodiesterase 4 inhibitor		PDE4C	phosphodiesterase 4C	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT01703260
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1042	CHOLECALCIFEROL	Small molecule	Vitamin D receptor agonist		VDR	vitamin D receptor	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05578404
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2105721	NIVOCASAN	Small molecule	Caspase-8 inhibitor		CASP8	caspase 8	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00740610
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03987451,https://clinicaltrials.gov/ct2/show/NCT02970942
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297576	EFINOPEGDUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04944992
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4091374	LANIFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03008070
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL230158	SELADELPAR	Small molecule	Peroxisome proliferator-activated receptor delta agonist		PPARD	peroxisome proliferator activated receptor delta	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT03551522
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL606	MISOPROSTOL	Small molecule	Prostanoid EP3 receptor agonist		PTGER3	prostaglandin E receptor 3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT05804305
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF4	NADH:ubiquinone oxidoreductase complex assembly factor 4	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297530	SAROGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03061721
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV2	NADH:ubiquinone oxidoreductase core subunit V2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP6	caspase 6	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE2A	phosphodiesterase 2A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297909	FAZPILODEMAB	Antibody	FGF1/KLB agonist		FGF1	fibroblast growth factor 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04171765
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP10	caspase 10	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297578	PEGBELFERMIN	Protein	FGF1/KLB agonist		KLB	klotho beta	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02413372,https://clinicaltrials.gov/ct2/show/NCT03400163
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB3	NADH:ubiquinone oxidoreductase subunit B3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV1	NADH:ubiquinone oxidoreductase core subunit V1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4L	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP4	caspase 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS6	NADH:ubiquinone oxidoreductase subunit S6	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF3	NADH:ubiquinone oxidoreductase complex assembly factor 3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA3	NADH:ubiquinone oxidoreductase subunit A3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE7B	phosphodiesterase 7B	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00590161,https://clinicaltrials.gov/ct2/show/NCT00267670
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3407547	FIRSOCOSTAT	Small molecule	Acetyl-CoA carboxylase negative allosteric modulator		ACACB	acetyl-CoA carboxylase beta	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04971785
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL457748	MB07811	Small molecule	Thyroid hormone receptor beta-1 agonist		THRB	thyroid hormone receptor beta	2	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT04173065
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB10	NADH:ubiquinone oxidoreductase subunit B10	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4567446	CLESACOSTAT	Small molecule	Acetyl-CoA carboxylase inhibitor		ACACA	acetyl-CoA carboxylase alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03776175
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL193240	ROFLUMILAST	Small molecule	Phosphodiesterase 4 inhibitor		PDE4D	phosphodiesterase 4D	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT01703260
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB11	NADH:ubiquinone oxidoreductase subunit B11	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA13	NADH:ubiquinone oxidoreductase subunit A13	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL121	ROSIGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1566	ACARBOSE	Oligosaccharide	Pancreatic alpha-amylase inhibitor		AMY2A	amylase alpha 2A	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT00677521
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL843	ROSIGLITAZONE MALEATE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3261331	RESMETIROM	Small molecule	Thyroid hormone receptor beta-1 agonist		THRB	thyroid hormone receptor beta	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT02912260
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297909	FAZPILODEMAB	Antibody	FGF1/KLB agonist		KLB	klotho beta	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04171765
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL672	FENOFIBRATE	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02781584
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC1	NADH:ubiquinone oxidoreductase subunit C1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297530	SAROGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03863574
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4298169	TROPIFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04065841
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL191	LOSARTAN	Small molecule	Type-1 angiotensin II receptor antagonist		AGTR1	angiotensin II receptor type 1	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT03467217
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2110727	CENICRIVIROC	Small molecule	C-C chemokine receptor type 2 antagonist		CCR2	C-C motif chemokine receptor 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02217475
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4084119	LIRAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01237119
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4298169	TROPIFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT04147195
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB7	NADH:ubiquinone oxidoreductase subunit B7	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297625	LICOGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04065841
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL566315	OBETICHOLIC ACID	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01265498,https://clinicaltrials.gov/ct2/show/NCT02633956
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA5	NADH:ubiquinone oxidoreductase subunit A5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4091374	LANIFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03008070
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3545113	PX-102	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01999101
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL393220	ATORVASTATIN CALCIUM	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04679376
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT03884075,https://clinicaltrials.gov/ct2/show/NCT05016882
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP1	caspase 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC2	NADH:ubiquinone oxidoreductase subunit C2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4L	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB2	NADH:ubiquinone oxidoreductase subunit B2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4L2	NDUFA4 mitochondrial complex associated like 2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND2	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6H	phosphodiesterase 6H	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA12	NADH:ubiquinone oxidoreductase subunit A12	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2105721	NIVOCASAN	Small molecule	Caspase-9 inhibitor		CASP9	caspase 9	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00740610
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297839	TIRZEPATIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT04166773
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4298169	TROPIFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT02855164
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE5A	phosphodiesterase 5A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2105711	TOFOGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05327127
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL995	LOSARTAN POTASSIUM	Small molecule	Type-1 angiotensin II receptor antagonist		AGTR1	angiotensin II receptor type 1	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT03467217
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4567446	CLESACOSTAT	Small molecule	Acetyl-CoA carboxylase inhibitor		ACACA	acetyl-CoA carboxylase alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03248882,https://clinicaltrials.gov/ct2/show/NCT04399538
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4650349	CHIGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05193916
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS8	NADH:ubiquinone oxidoreductase core subunit S8	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE9A	phosphodiesterase 9A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1237	LISINOPRIL	Small molecule	Angiotensin-converting enzyme inhibitor		ACE	angiotensin I converting enzyme	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04550481
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL95889	BETAINE	Small molecule	Betaine-homocysteine S-methyltransferase substrate		BHMT	betaine--homocysteine S-methyltransferase	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00586911
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP5	caspase 5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04944992,https://clinicaltrials.gov/ct2/show/NCT03987074
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6A	phosphodiesterase 6A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00590161,https://clinicaltrials.gov/ct2/show/NCT00267670
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS7	NADH:ubiquinone oxidoreductase core subunit S7	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2107857	METRELEPTIN	Protein	Leptin receptor agonist		LEPR	leptin receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00596934
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297626	NIDUFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT02913105
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1C	phosphodiesterase 1C	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL393220	ATORVASTATIN CALCIUM	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT01617772
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND6	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4567446	CLESACOSTAT	Small molecule	Acetyl-CoA carboxylase inhibitor		ACACB	acetyl-CoA carboxylase beta	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04399538,https://clinicaltrials.gov/ct2/show/NCT03248882
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297630	COTADUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04019561
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3545412	K-877	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05327127
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL595	PIOGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT01703260
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA10	NADH:ubiquinone oxidoreductase subunit A10	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB9	NADH:ubiquinone oxidoreductase subunit B9	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB4	NADH:ubiquinone oxidoreductase subunit B4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1B	phosphodiesterase 1B	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00590161,https://clinicaltrials.gov/ct2/show/NCT00267670
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1751	DIGOXIN	Small molecule	Sodium/potassium-transporting ATPase inhibitor		ATP1A4	ATPase Na+/K+ transporting subunit alpha 4	2	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT04216693
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4	NDUFA4 mitochondrial complex associated	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL595	PIOGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00013598
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE7A	phosphodiesterase 7A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00590161,https://clinicaltrials.gov/ct2/show/NCT00267670
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3746388	TERN-101	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04328077
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND3	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2105721	NIVOCASAN	Small molecule	Caspase-1 inhibitor		CASP1	caspase 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00740610
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV2	NADH:ubiquinone oxidoreductase core subunit V2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB1	NADH:ubiquinone oxidoreductase subunit B1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL595	PIOGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00633282
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1201621	SOMATROPIN	Protein	Growth hormone receptor agonist		GHR	growth hormone receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02217345
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297613	CILOFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04971785
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297530	SAROGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05211284
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4567446	CLESACOSTAT	Small molecule	Acetyl-CoA carboxylase inhibitor		ACACB	acetyl-CoA carboxylase beta	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03776175
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB8	NADH:ubiquinone oxidoreductase subunit B8	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2107830	EMPAGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT03867487
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3746388	TERN-101	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05415722
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3407547	FIRSOCOSTAT	Small molecule	Acetyl-CoA carboxylase negative allosteric modulator		ACACA	acetyl-CoA carboxylase alpha	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04971785
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4A	phosphodiesterase 4A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00590161,https://clinicaltrials.gov/ct2/show/NCT00267670
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3916717	SELONSERTIB	Small molecule	Mitogen-activated protein kinase kinase kinase 5 inhibitor		MAP3K5	mitogen-activated protein kinase kinase kinase 5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02466516
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE3B	phosphodiesterase 3B	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1164729	FEBUXOSTAT	Small molecule	Xanthine dehydrogenase inhibitor		XDH	xanthine dehydrogenase	2	Not yet recruiting	https://clinicaltrials.gov/ct2/show/NCT04772352
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297630	COTADUTIDE	Protein	Glucagon receptor agonist		GCGR	glucagon receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04019561
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL95889	BETAINE	Small molecule	Betaine-homocysteine S-methyltransferase substrate		BHMT2	betaine--homocysteine S-methyltransferase 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00586911
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2110731	TOFOGLIFLOZIN	Small molecule	Sodium/glucose cotransporter 2 inhibitor		SLC5A2	solute carrier family 5 member 2	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05327127
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4091374	LANIFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARD	peroxisome proliferator activated receptor delta	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03008070
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3545412	K-877	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03350165
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2110727	CENICRIVIROC	Small molecule	C-C chemokine receptor type 2 antagonist		CCR2	C-C motif chemokine receptor 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03517540
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB6	NADH:ubiquinone oxidoreductase subunit B6	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2109343	LERONLIMAB	Antibody	C-C chemokine receptor type 5 antagonist		CCR5	C-C motif chemokine receptor 5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04521114
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF2	NADH:ubiquinone oxidoreductase complex assembly factor 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4298055	ALDAFERMIN	Protein	FGF1/KLB activator		KLB	klotho beta	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03912532,https://clinicaltrials.gov/ct2/show/NCT02443116
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP9	caspase 9	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS3	NADH:ubiquinone oxidoreductase core subunit S3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA6	NADH:ubiquinone oxidoreductase subunit A6	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB7	NADH:ubiquinone oxidoreductase subunit B7	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB11	NADH:ubiquinone oxidoreductase subunit B11	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE1A	phosphodiesterase 1A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00590161,https://clinicaltrials.gov/ct2/show/NCT00267670
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL414357	EXENATIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00650546
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV1	NADH:ubiquinone oxidoreductase core subunit V1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1201631	INSULIN	Protein	Insulin receptor agonist		INSR	insulin receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02653300
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB4	NADH:ubiquinone oxidoreductase subunit B4	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP7	caspase 7	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL393220	ATORVASTATIN CALCIUM	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02633956
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1487	ATORVASTATIN	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02633956
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3407547	FIRSOCOSTAT	Small molecule	Acetyl-CoA carboxylase negative allosteric modulator		ACACA	acetyl-CoA carboxylase alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03987074,https://clinicaltrials.gov/ct2/show/NCT02781584,https://clinicaltrials.gov/ct2/show/NCT03449446,https://clinicaltrials.gov/ct2/show/NCT02856555
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE8B	phosphodiesterase 8B	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297530	SAROGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03061721
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA5	NADH:ubiquinone oxidoreductase subunit A5	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE4D	phosphodiesterase 4D	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE3A	phosphodiesterase 3A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND1	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB1	NADH:ubiquinone oxidoreductase subunit B1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3707395	ELAFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01694849
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND5	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB6	NADH:ubiquinone oxidoreductase subunit B6	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA9	NADH:ubiquinone oxidoreductase subunit A9	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3707395	ELAFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor delta agonist		PPARD	peroxisome proliferator activated receptor delta	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT03883607
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC1	NADH:ubiquinone oxidoreductase subunit C1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA10	NADH:ubiquinone oxidoreductase subunit A10	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1422	SITAGLIPTIN	Small molecule	Dipeptidyl peptidase IV inhibitor		DPP4	dipeptidyl peptidase 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01963845
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA12	NADH:ubiquinone oxidoreductase subunit A12	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2364624	PRADIGASTAT	Small molecule	Diacylglycerol O-acyltransferase 1 inhibitor		DGAT1	diacylglycerol O-acyltransferase 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01811472
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3707395	ELAFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor delta agonist		PPARD	peroxisome proliferator activated receptor delta	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01694849
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA2	NADH:ubiquinone oxidoreductase subunit A2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS4	NADH:ubiquinone oxidoreductase subunit S4	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL193240	ROFLUMILAST	Small molecule	Phosphodiesterase 4 inhibitor		PDE4A	phosphodiesterase 4A	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT01703260
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB9	NADH:ubiquinone oxidoreductase subunit B9	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL2110727	CENICRIVIROC	Small molecule	C-C chemokine receptor type 5 antagonist		CCR5	C-C motif chemokine receptor 5	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02217475
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL982	NALMEFENE	Small molecule	Opioid receptors; mu/kappa/delta antagonist		OPRD1	opioid receptor delta 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02442687
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4L2	NDUFA4 mitochondrial complex associated like 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4298169	TROPIFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03517540
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3039515	ELOBIXIBAT	Small molecule	Ileal bile acid transporter inhibitor		SLC10A2	solute carrier family 10 member 2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT04006145
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF3	NADH:ubiquinone oxidoreductase complex assembly factor 3	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS3	NADH:ubiquinone oxidoreductase core subunit S3	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4650349	CHIGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05193916
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS2	NADH:ubiquinone oxidoreductase core subunit S2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND5	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE10A	phosphodiesterase 10A	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6D	phosphodiesterase 6D	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	Adenosine A2 receptor antagonist		ADORA2A	adenosine A2a receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297530	SAROGLITAZAR	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03863574
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1487	ATORVASTATIN	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT01617772
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL193240	ROFLUMILAST	Small molecule	Phosphodiesterase 4 inhibitor		PDE4B	phosphodiesterase 4B	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT01703260
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6C	phosphodiesterase 6C	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC2	NADH:ubiquinone oxidoreductase subunit C2	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297839	TIRZEPATIDE	Protein	Gastric inhibitory polypeptide receptor agonist		GIPR	gastric inhibitory polypeptide receptor	2	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT04166773
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL566315	OBETICHOLIC ACID	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	2	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT05573204
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1487	ATORVASTATIN	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	2	Recruiting	https://clinicaltrials.gov/ct2/show/NCT04679376
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	Inhibitor	GPD2	glycerol-3-phosphate dehydrogenase 2	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297588	ODEVIXIBAT	Small molecule	Ileal bile acid transporter inhibitor		SLC10A2	solute carrier family 10 member 2	2	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT03451279
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA9	NADH:ubiquinone oxidoreductase subunit A9	2	Completed	https://clinicaltrials.gov/ct2/show/NCT03850886
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1138	EZETIMIBE	Small molecule	Niemann-Pick C1-like protein 1 inhibitor		NPC1L1	NPC1 like intracellular cholesterol transporter 1	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01766713
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL197672	EMRICASAN	Small molecule	Caspase inhibitor		CASP3	caspase 3	2	Completed	https://clinicaltrials.gov/ct2/show/NCT02077374
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1042	CHOLECALCIFEROL	Small molecule	Vitamin D receptor agonist		VDR	vitamin D receptor	2	Completed	https://clinicaltrials.gov/ct2/show/NCT01571063
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB8	NADH:ubiquinone oxidoreductase subunit B8	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6B	phosphodiesterase 6B	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL121	ROSIGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00492700
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL3707395	ELAFIBRANOR	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	2	Terminated	https://clinicaltrials.gov/ct2/show/NCT03883607
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND3	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3	2	Unknown status	https://clinicaltrials.gov/ct2/show/NCT00699036
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL628	PENTOXIFYLLINE	Small molecule	3',5'-cyclic phosphodiesterase inhibitor		PDE6G	phosphodiesterase 6G	2	Completed	https://clinicaltrials.gov/ct2/show/NCT00267670,https://clinicaltrials.gov/ct2/show/NCT00590161
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND6	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA1	NADH:ubiquinone oxidoreductase subunit A1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV3	NADH:ubiquinone oxidoreductase subunit V3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS3	NADH:ubiquinone oxidoreductase core subunit S3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA2	NADH:ubiquinone oxidoreductase subunit A2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV3	NADH:ubiquinone oxidoreductase subunit V3	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF3	NADH:ubiquinone oxidoreductase complex assembly factor 3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN3A	sodium voltage-gated channel alpha subunit 3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND3	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA11	NADH:ubiquinone oxidoreductase subunit A11	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN8A	sodium voltage-gated channel alpha subunit 8	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC2	NADH:ubiquinone oxidoreductase subunit C2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF3	NADH:ubiquinone oxidoreductase complex assembly factor 3	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB6	NADH:ubiquinone oxidoreductase subunit B6	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB8	NADH:ubiquinone oxidoreductase subunit B8	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA11	NADH:ubiquinone oxidoreductase subunit A11	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1487	ATORVASTATIN	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL539697	DABIGATRAN ETEXILATE	Small molecule	Thrombin inhibitor		F2	coagulation factor II, thrombin	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03143166
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB9	NADH:ubiquinone oxidoreductase subunit B9	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	Inhibitor	GPD2	glycerol-3-phosphate dehydrogenase 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297578	PEGBELFERMIN	Protein	FGF1/KLB agonist		FGF1	fibroblast growth factor 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03674476
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1751	DIGOXIN	Small molecule	Sodium/potassium-transporting ATPase inhibitor		ATP1A3	ATPase Na+/K+ transporting subunit alpha 3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV2	NADH:ubiquinone oxidoreductase core subunit V2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS4	NADH:ubiquinone oxidoreductase subunit S4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND1	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB7	NADH:ubiquinone oxidoreductase subunit B7	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL655	MIDAZOLAM	Small molecule	GABA-A receptor; anion channel positive allosteric modulator		GABRA1	gamma-aminobutyric acid type A receptor subunit alpha1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1389	LEVONORGESTREL	Small molecule	Progesterone receptor agonist		PGR	progesterone receptor	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB6	NADH:ubiquinone oxidoreductase subunit B6	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND1	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS4	NADH:ubiquinone oxidoreductase subunit S4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF4	NADH:ubiquinone oxidoreductase complex assembly factor 4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL113	CAFFEINE	Small molecule	Adenosine receptor antagonist		ADORA1	adenosine A1 receptor	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF4	NADH:ubiquinone oxidoreductase complex assembly factor 4	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL655	MIDAZOLAM	Small molecule	GABA-A receptor; anion channel positive allosteric modulator		GABRA3	gamma-aminobutyric acid type A receptor subunit alpha3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297630	COTADUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	1	Terminated	https://clinicaltrials.gov/ct2/show/NCT05668936
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB10	NADH:ubiquinone oxidoreductase subunit B10	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA10	NADH:ubiquinone oxidoreductase subunit A10	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND2	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB2	NADH:ubiquinone oxidoreductase subunit B2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1751	DIGOXIN	Small molecule	Sodium/potassium-transporting ATPase inhibitor		ATP1A1	ATPase Na+/K+ transporting subunit alpha 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF2	NADH:ubiquinone oxidoreductase complex assembly factor 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB1	NADH:ubiquinone oxidoreductase subunit B1	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL655	MIDAZOLAM	Small molecule	GABA-A receptor; anion channel positive allosteric modulator		GABRG3	gamma-aminobutyric acid type A receptor subunit gamma3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND2	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN5A	sodium voltage-gated channel alpha subunit 5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB11	NADH:ubiquinone oxidoreductase subunit B11	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03357380
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS4	NADH:ubiquinone oxidoreductase subunit S4	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC1	NADH:ubiquinone oxidoreductase subunit C1	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS6	NADH:ubiquinone oxidoreductase subunit S6	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL655	MIDAZOLAM	Small molecule	GABA-A receptor; anion channel positive allosteric modulator		GABRG1	gamma-aminobutyric acid type A receptor subunit gamma1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1751	DIGOXIN	Small molecule	Sodium/potassium-transporting ATPase inhibitor		ATP1A4	ATPase Na+/K+ transporting subunit alpha 4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4	NDUFA4 mitochondrial complex associated	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB10	NADH:ubiquinone oxidoreductase subunit B10	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN11A	sodium voltage-gated channel alpha subunit 11	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS5	NADH:ubiquinone oxidoreductase subunit S5	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF2	NADH:ubiquinone oxidoreductase complex assembly factor 2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA6	NADH:ubiquinone oxidoreductase subunit A6	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB7	NADH:ubiquinone oxidoreductase subunit B7	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4L	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA3	NADH:ubiquinone oxidoreductase subunit A3	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL655	MIDAZOLAM	Small molecule	GABA-A receptor; anion channel positive allosteric modulator		GABRG2	gamma-aminobutyric acid type A receptor subunit gamma2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF4	NADH:ubiquinone oxidoreductase complex assembly factor 4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV1	NADH:ubiquinone oxidoreductase core subunit V1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4567446	CLESACOSTAT	Small molecule	Acetyl-CoA carboxylase inhibitor		ACACB	acetyl-CoA carboxylase beta	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT04395950
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL655	MIDAZOLAM	Small molecule	GABA-A receptor; anion channel positive allosteric modulator		GABRA5	gamma-aminobutyric acid type A receptor subunit alpha5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB2	NADH:ubiquinone oxidoreductase subunit B2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF3	NADH:ubiquinone oxidoreductase complex assembly factor 3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS5	NADH:ubiquinone oxidoreductase subunit S5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS8	NADH:ubiquinone oxidoreductase core subunit S8	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA9	NADH:ubiquinone oxidoreductase subunit A9	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS8	NADH:ubiquinone oxidoreductase core subunit S8	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB4	NADH:ubiquinone oxidoreductase subunit B4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND6	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC2	NADH:ubiquinone oxidoreductase subunit C2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA3	NADH:ubiquinone oxidoreductase subunit A3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4	NDUFA4 mitochondrial complex associated	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA13	NADH:ubiquinone oxidoreductase subunit A13	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1715	PIOGLITAZONE HYDROCHLORIDE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01431521
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV2	NADH:ubiquinone oxidoreductase core subunit V2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL595	PIOGLITAZONE	Small molecule	Peroxisome proliferator-activated receptor gamma agonist		PPARG	peroxisome proliferator activated receptor gamma	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01431521
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF2	NADH:ubiquinone oxidoreductase complex assembly factor 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1751	DIGOXIN	Small molecule	Sodium/potassium-transporting ATPase inhibitor		ATP1A2	ATPase Na+/K+ transporting subunit alpha 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS7	NADH:ubiquinone oxidoreductase core subunit S7	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV1	NADH:ubiquinone oxidoreductase core subunit V1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS7	NADH:ubiquinone oxidoreductase core subunit S7	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4L2	NDUFA4 mitochondrial complex associated like 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4567446	CLESACOSTAT	Small molecule	Acetyl-CoA carboxylase inhibitor		ACACA	acetyl-CoA carboxylase alpha	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT04395950
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB7	NADH:ubiquinone oxidoreductase subunit B7	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL787	MONTELUKAST	Small molecule	Cysteinyl leukotriene receptor 1 antagonist		CYSLTR1	cysteinyl leukotriene receptor 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04080947
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS7	NADH:ubiquinone oxidoreductase core subunit S7	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1393	SPIRONOLACTONE	Small molecule	Mineralocorticoid receptor antagonist		NR3C2	nuclear receptor subfamily 3 group C member 2	1	Active, not recruiting	https://clinicaltrials.gov/ct2/show/NCT03576755
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN9A	sodium voltage-gated channel alpha subunit 9	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA5	NADH:ubiquinone oxidoreductase subunit A5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA12	NADH:ubiquinone oxidoreductase subunit A12	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN7A	sodium voltage-gated channel alpha subunit 7	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS2	NADH:ubiquinone oxidoreductase core subunit S2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV1	NADH:ubiquinone oxidoreductase core subunit V1	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND5	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4L	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND2	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB10	NADH:ubiquinone oxidoreductase subunit B10	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297630	COTADUTIDE	Protein	Glucagon receptor agonist		GCGR	glucagon receptor	1	Terminated	https://clinicaltrials.gov/ct2/show/NCT05668936
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB4	NADH:ubiquinone oxidoreductase subunit B4	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA9	NADH:ubiquinone oxidoreductase subunit A9	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	Inhibitor	GPD2	glycerol-3-phosphate dehydrogenase 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB9	NADH:ubiquinone oxidoreductase subunit B9	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND3	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND1	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA1	NADH:ubiquinone oxidoreductase subunit A1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297578	PEGBELFERMIN	Protein	FGF1/KLB agonist		KLB	klotho beta	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03674476
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA2	NADH:ubiquinone oxidoreductase subunit A2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN10A	sodium voltage-gated channel alpha subunit 10	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL4297613	CILOFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02654002,https://clinicaltrials.gov/ct2/show/NCT02808312
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA10	NADH:ubiquinone oxidoreductase subunit A10	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA3	NADH:ubiquinone oxidoreductase subunit A3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA5	NADH:ubiquinone oxidoreductase subunit A5	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN1A	sodium voltage-gated channel alpha subunit 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4L2	NDUFA4 mitochondrial complex associated like 2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS3	NADH:ubiquinone oxidoreductase core subunit S3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA12	NADH:ubiquinone oxidoreductase subunit A12	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB2	NADH:ubiquinone oxidoreductase subunit B2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND5	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL393220	ATORVASTATIN CALCIUM	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS8	NADH:ubiquinone oxidoreductase core subunit S8	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS5	NADH:ubiquinone oxidoreductase subunit S5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA11	NADH:ubiquinone oxidoreductase subunit A11	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL113	CAFFEINE	Small molecule	Adenosine receptor antagonist		ADORA3	adenosine A3 receptor	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA13	NADH:ubiquinone oxidoreductase subunit A13	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB6	NADH:ubiquinone oxidoreductase subunit B6	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL655	MIDAZOLAM	Small molecule	GABA-A receptor; anion channel positive allosteric modulator		GABRA2	gamma-aminobutyric acid type A receptor subunit alpha2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4297577	BELAPECTIN	Unknown	Galectin-3 inhibitor		LGALS3	galectin 3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01899859
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB11	NADH:ubiquinone oxidoreductase subunit B11	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB3	NADH:ubiquinone oxidoreductase subunit B3	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB1	NADH:ubiquinone oxidoreductase subunit B1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC2	NADH:ubiquinone oxidoreductase subunit C2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB3	NADH:ubiquinone oxidoreductase subunit B3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA9	NADH:ubiquinone oxidoreductase subunit A9	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS6	NADH:ubiquinone oxidoreductase subunit S6	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS2	NADH:ubiquinone oxidoreductase core subunit S2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA13	NADH:ubiquinone oxidoreductase subunit A13	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL113	CAFFEINE	Small molecule	Adenosine receptor antagonist		ADORA2B	adenosine A2b receptor	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4L2	NDUFA4 mitochondrial complex associated like 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS2	NADH:ubiquinone oxidoreductase core subunit S2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN4A	sodium voltage-gated channel alpha subunit 4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1464	WARFARIN	Small molecule	Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor		VKORC1	vitamin K epoxide reductase complex subunit 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL316561	PROGLUMIDE	Small molecule	Cholecystokinin receptor antagonist		CCKAR	cholecystokinin A receptor	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04152473
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV2	NADH:ubiquinone oxidoreductase core subunit V2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND6	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB11	NADH:ubiquinone oxidoreductase subunit B11	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL316561	PROGLUMIDE	Small molecule	Cholecystokinin receptor antagonist		CCKBR	cholecystokinin B receptor	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04152473
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3407547	FIRSOCOSTAT	Small molecule	Acetyl-CoA carboxylase negative allosteric modulator		ACACB	acetyl-CoA carboxylase beta	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02891408
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA6	NADH:ubiquinone oxidoreductase subunit A6	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL2108724	SEMAGLUTIDE	Protein	Glucagon-like peptide 1 receptor agonist		GLP1R	glucagon like peptide 1 receptor	1	Recruiting	https://clinicaltrials.gov/ct2/show/NCT05766709
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1294	QUINIDINE	Small molecule	Sodium channel alpha subunit blocker		SCN2A	sodium voltage-gated channel alpha subunit 2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03610945
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA12	NADH:ubiquinone oxidoreductase subunit A12	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND3	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC1	NADH:ubiquinone oxidoreductase subunit C1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS3	NADH:ubiquinone oxidoreductase core subunit S3	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA10	NADH:ubiquinone oxidoreductase subunit A10	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA5	NADH:ubiquinone oxidoreductase subunit A5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL4298169	TROPIFEXOR	Small molecule	Bile acid receptor FXR agonist		NR1H4	nuclear receptor subfamily 1 group H member 4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03681457
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA2	NADH:ubiquinone oxidoreductase subunit A2	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFV3	NADH:ubiquinone oxidoreductase subunit V3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB9	NADH:ubiquinone oxidoreductase subunit B9	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB1	NADH:ubiquinone oxidoreductase subunit B1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA6	NADH:ubiquinone oxidoreductase subunit A6	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS6	NADH:ubiquinone oxidoreductase subunit S6	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFC1	NADH:ubiquinone oxidoreductase subunit C1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL3407547	FIRSOCOSTAT	Small molecule	Acetyl-CoA carboxylase negative allosteric modulator		ACACA	acetyl-CoA carboxylase alpha	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02891408
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA4	NDUFA4 mitochondrial complex associated	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1496	ROSUVASTATIN	Small molecule	HMG-CoA reductase inhibitor		HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB4	NADH:ubiquinone oxidoreductase subunit B4	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL691	ETHINYL ESTRADIOL	Small molecule	Estrogen receptor alpha agonist		ESR1	estrogen receptor 1	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB8	NADH:ubiquinone oxidoreductase subunit B8	1	Completed	https://clinicaltrials.gov/ct2/show/NCT01084486,https://clinicaltrials.gov/ct2/show/NCT02696941
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	Inhibitor	GPD2	glycerol-3-phosphate dehydrogenase 2	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFA1	NADH:ubiquinone oxidoreductase subunit A1	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB8	NADH:ubiquinone oxidoreductase subunit B8	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL113	CAFFEINE	Small molecule	Adenosine receptor antagonist		ADORA2A	adenosine A2a receptor	1	Completed	https://clinicaltrials.gov/ct2/show/NCT03187496
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND4L	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFS1	NADH:ubiquinone oxidoreductase core subunit S1	1	Withdrawn	https://clinicaltrials.gov/ct2/show/NCT02457286
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	NDUFB3	NADH:ubiquinone oxidoreductase subunit B3	1	Completed	https://clinicaltrials.gov/ct2/show/NCT04972396
EFO_0003095	non-alcoholic fatty liver disease	CHEMBL1431	METFORMIN	Small molecule	Mitochondrial complex I (NADH dehydrogenase) inhibitor	Inhibitor	MT-ND5	mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02696941,https://clinicaltrials.gov/ct2/show/NCT01084486
EFO_1001249	non-alcoholic steatohepatitis	CHEMBL672	FENOFIBRATE	Small molecule	Peroxisome proliferator-activated receptor alpha agonist		PPARA	peroxisome proliferator activated receptor alpha	1	Completed	https://clinicaltrials.gov/ct2/show/NCT02891408